Neurocarrus is a biotechnology company developing a novel drug delivery technology to safely disrupt pain signals without addiction-forming medications or disruption of muscular control. Their first-in-class therapeutic (N-001) is designed to treat the physiological symptoms of pain without invasive surgical procedures or systemically absorbed drugs.

Biotechnology

Neurocarrus

Paul Blum

The leadership team at Neurocarrus has a wealth of experience in academia. Both the Adjunct Professor and the Professor have taught at prestigious universities, such as the University of California, Santa Cruz, and the University of Nebraska. This experience gives them a deep understanding of the latest research in the field of neuroscience. In addition, the Adjunct Professor has also worked in industry, giving her a unique perspective on how to apply this research to real-world problems.

Leadership Team

About

Team members

Other teams at Neurocarrus

Board of Directors

CEO and Executive Team

Founding Team